Published in Healthcare Mergers, Acquisitions and Ventures Week, May 19th, 2007
For more than 20 years, small biotech companies were able to compete for SBIR grants until an arbitrary Small Business Administration interpretation of SBIR eligibility standards in 2003 effectively excluded many biotech...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.